<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Genome and clonal hematopoiesis stability contrasts with immune, cfDNA, mitochondrial, and telomere length changes during short duration spaceflight</title>
				<funder ref="#_3Trkfch">
					<orgName type="full">WorldQuant Foundation, NASA</orgName>
				</funder>
				<funder ref="#_w7VbgKA">
					<orgName type="full">Leukemia and Lymphoma Society</orgName>
				</funder>
				<funder ref="#_7cNmt3q #_egX6AJn #_HQd6fSB #_8xnqgu7 #_Pm32shw #_Jg9H4zQ #_6kp37VB #_3SZCAbq">
					<orgName type="full">unknown</orgName>
				</funder>
				<funder ref="#_8yWvPPu">
					<orgName type="full">National Institutes of Health</orgName>
				</funder>
			</titleStmt>
			<publicationStmt>
				<publisher>Oxford University Press (OUP)</publisher>
				<availability  status="unknown">
					<licence/>
				</availability>
				<date type="published" when="2024-04-08">8 April 2024</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">J</forename><forename type="middle">Sebastian</forename><surname>Garcia-Medina</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Karolina</forename><surname>Sienkiewicz</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Department of Physiology and Biophysics</orgName>
								<orgName type="department" key="dep2">Weill Cornell Medicine</orgName>
								<orgName type="institution">Cornell Univ ersity</orgName>
								<address>
									<postCode>10021</postCode>
									<settlement>Ne w York</settlement>
									<region>NY</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">The HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsaud Institute for Computational Biomedicine</orgName>
								<orgName type="institution">Weill Cornell Medicine</orgName>
								<address>
									<postCode>10021</postCode>
									<settlement>New York</settlement>
									<region>NY</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">S</forename><forename type="middle">Anand</forename><surname>Narayanan</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Eliah</forename><forename type="middle">G</forename><surname>Overbey</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Kirill</forename><surname>Grigorev</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Krista</forename><forename type="middle">A</forename><surname>Ryon</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Department of Physiology and Biophysics</orgName>
								<orgName type="department" key="dep2">Weill Cornell Medicine</orgName>
								<orgName type="institution">Cornell Univ ersity</orgName>
								<address>
									<postCode>10021</postCode>
									<settlement>Ne w York</settlement>
									<region>NY</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Marissa</forename><surname>Burke</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Department of Physiology and Biophysics</orgName>
								<orgName type="department" key="dep2">Weill Cornell Medicine</orgName>
								<orgName type="institution">Cornell Univ ersity</orgName>
								<address>
									<postCode>10021</postCode>
									<settlement>Ne w York</settlement>
									<region>NY</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Jacqueline</forename><surname>Proszynski</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Department of Physiology and Biophysics</orgName>
								<orgName type="department" key="dep2">Weill Cornell Medicine</orgName>
								<orgName type="institution">Cornell Univ ersity</orgName>
								<address>
									<postCode>10021</postCode>
									<settlement>Ne w York</settlement>
									<region>NY</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Braden</forename><surname>Tierney</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Department of Physiology and Biophysics</orgName>
								<orgName type="department" key="dep2">Weill Cornell Medicine</orgName>
								<orgName type="institution">Cornell Univ ersity</orgName>
								<address>
									<postCode>10021</postCode>
									<settlement>Ne w York</settlement>
									<region>NY</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">The HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsaud Institute for Computational Biomedicine</orgName>
								<orgName type="institution">Weill Cornell Medicine</orgName>
								<address>
									<postCode>10021</postCode>
									<settlement>New York</settlement>
									<region>NY</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Caleb</forename><forename type="middle">M</forename><surname>Schmidt</surname></persName>
							<affiliation key="aff6">
								<orgName type="institution">Sov aris Aer ospace</orgName>
								<address>
									<postCode>80302</postCode>
									<settlement>Boulder</settlement>
									<region>CO</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
							<affiliation key="aff7">
								<orgName type="department">Adv anced P attern Anal ysis &amp; Human Performance Gr oup</orgName>
								<address>
									<postCode>80302</postCode>
									<settlement>Boulder</settlement>
									<region>CO</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
							<affiliation key="aff11">
								<orgName type="department">Department of Systems Engineering</orgName>
								<orgName type="institution">Colorado State University</orgName>
								<address>
									<postCode>80523</postCode>
									<settlement>Fort Collins</settlement>
									<region>CO</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Nuria</forename><surname>Mencia-Trinchant</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Department of Physiology and Biophysics</orgName>
								<orgName type="department" key="dep2">Weill Cornell Medicine</orgName>
								<orgName type="institution">Cornell Univ ersity</orgName>
								<address>
									<postCode>10021</postCode>
									<settlement>Ne w York</settlement>
									<region>NY</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Remi</forename><surname>Klotz</surname></persName>
							<affiliation key="aff3">
								<orgName type="department">Department of Stem Cell Biology and Regener ativ e Medicine</orgName>
								<address>
									<settlement>K</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Veronica</forename><surname>Ortiz</surname></persName>
							<affiliation key="aff3">
								<orgName type="department">Department of Stem Cell Biology and Regener ativ e Medicine</orgName>
								<address>
									<settlement>K</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Jonathan</forename><surname>Foox</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Department of Physiology and Biophysics</orgName>
								<orgName type="department" key="dep2">Weill Cornell Medicine</orgName>
								<orgName type="institution">Cornell Univ ersity</orgName>
								<address>
									<postCode>10021</postCode>
									<settlement>Ne w York</settlement>
									<region>NY</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">The HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsaud Institute for Computational Biomedicine</orgName>
								<orgName type="institution">Weill Cornell Medicine</orgName>
								<address>
									<postCode>10021</postCode>
									<settlement>New York</settlement>
									<region>NY</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Christopher</forename><surname>Chin</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Department of Physiology and Biophysics</orgName>
								<orgName type="department" key="dep2">Weill Cornell Medicine</orgName>
								<orgName type="institution">Cornell Univ ersity</orgName>
								<address>
									<postCode>10021</postCode>
									<settlement>Ne w York</settlement>
									<region>NY</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">The HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsaud Institute for Computational Biomedicine</orgName>
								<orgName type="institution">Weill Cornell Medicine</orgName>
								<address>
									<postCode>10021</postCode>
									<settlement>New York</settlement>
									<region>NY</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
							<affiliation key="aff15">
								<orgName type="institution">BioAstr a Inc</orgName>
								<address>
									<settlement>Ne w York</settlement>
									<region>NY</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
							<affiliation key="aff18">
								<orgName type="department">T he F eil Famil y Br ain and Mind Researc h Institute</orgName>
								<orgName type="institution">Weill Cornell Medicine</orgName>
								<address>
									<postCode>10021</postCode>
									<region>NY</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Deena</forename><surname>Najjar</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Department of Physiology and Biophysics</orgName>
								<orgName type="department" key="dep2">Weill Cornell Medicine</orgName>
								<orgName type="institution">Cornell Univ ersity</orgName>
								<address>
									<postCode>10021</postCode>
									<settlement>Ne w York</settlement>
									<region>NY</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
							<affiliation key="aff19">
								<orgName type="department">WorldQuant Initiative for Quantitative Prediction</orgName>
								<orgName type="institution">Weill Cornell Medicine</orgName>
								<address>
									<postCode>10021</postCode>
									<settlement>New York</settlement>
									<region>NY</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Irina</forename><surname>Matei</surname></persName>
							<affiliation key="aff8">
								<orgName type="department" key="dep1">Children&apos;s Cancer and Blood Foundation Laboratories</orgName>
								<orgName type="department" key="dep2">Departments of Pediatrics and Cell and Developmental Biology</orgName>
								<orgName type="department" key="dep3">Meyer Cancer Center</orgName>
								<orgName type="institution" key="instit1">Drukier Institute for Children&apos;s Health</orgName>
								<orgName type="institution" key="instit2">Weill Cornell Medicine</orgName>
								<address>
									<postCode>10021</postCode>
									<settlement>New York</settlement>
									<region>NY</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
							<affiliation key="aff9">
								<orgName type="department">Meyer Cancer Center</orgName>
								<orgName type="institution">Weill Cornell Medicine</orgName>
								<address>
									<postCode>10065</postCode>
									<settlement>New York</settlement>
									<region>NY</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Irenaeus</forename><surname>Chan</surname></persName>
							<idno type="ORCID">0009-0004-3250-9626</idno>
							<affiliation key="aff16">
								<orgName type="institution">Washington University St. Louis Oncology Division</orgName>
								<address>
									<postCode>63100</postCode>
									<settlement>St. Louis</settlement>
									<region>MO</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Carlos</forename><surname>Cruchaga</surname></persName>
							<affiliation key="aff16">
								<orgName type="institution">Washington University St. Louis Oncology Division</orgName>
								<address>
									<postCode>63100</postCode>
									<settlement>St. Louis</settlement>
									<region>MO</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Ashley</forename><surname>Kleinman</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Department of Physiology and Biophysics</orgName>
								<orgName type="department" key="dep2">Weill Cornell Medicine</orgName>
								<orgName type="institution">Cornell Univ ersity</orgName>
								<address>
									<postCode>10021</postCode>
									<settlement>Ne w York</settlement>
									<region>NY</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Jangkeun</forename><surname>Kim</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Alexander</forename><surname>Lucaci</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Department of Physiology and Biophysics</orgName>
								<orgName type="department" key="dep2">Weill Cornell Medicine</orgName>
								<orgName type="institution">Cornell Univ ersity</orgName>
								<address>
									<postCode>10021</postCode>
									<settlement>Ne w York</settlement>
									<region>NY</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Conor</forename><surname>Loy</surname></persName>
							<affiliation key="aff17">
								<orgName type="department">Meinig School of Biomedical Engineering</orgName>
								<orgName type="institution">Cornell University</orgName>
								<address>
									<postCode>14853</postCode>
									<settlement>Ithaca</settlement>
									<region>NY</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Omary</forename><surname>Mzava</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Iwijn</forename><surname>De vlaminck</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Anvita</forename><surname>Singaraju</surname></persName>
							<affiliation key="aff2">
								<orgName type="department" key="dep1">Department of Immunology</orgName>
								<orgName type="department" key="dep2">Weill Cornell Medicine</orgName>
								<orgName type="institution">Cornell Univ ersity</orgName>
								<address>
									<postCode>10021</postCode>
									<settlement>Ne w York</settlement>
									<region>NY</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Lynn</forename><forename type="middle">E</forename><surname>Taylor</surname></persName>
							<affiliation key="aff13">
								<orgName type="department">Department of Environmental and Radiological Health Sciences</orgName>
								<orgName type="institution">Colorado State University</orgName>
								<address>
									<postCode>80523</postCode>
									<settlement>Fort Collins</settlement>
									<region>CO</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Julian</forename><forename type="middle">C</forename><surname>Schmidt</surname></persName>
							<affiliation key="aff6">
								<orgName type="institution">Sov aris Aer ospace</orgName>
								<address>
									<postCode>80302</postCode>
									<settlement>Boulder</settlement>
									<region>CO</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
							<affiliation key="aff7">
								<orgName type="department">Adv anced P attern Anal ysis &amp; Human Performance Gr oup</orgName>
								<address>
									<postCode>80302</postCode>
									<settlement>Boulder</settlement>
									<region>CO</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Michael</forename><forename type="middle">A</forename><surname>Schmidt</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Kelly</forename><surname>Blease</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Juan</forename><surname>Moreno</surname></persName>
							<affiliation key="aff12">
								<orgName type="department">Element Biosciences</orgName>
								<address>
									<postCode>10055</postCode>
									<settlement>San Diego</settlement>
									<region>CA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Andrew</forename><surname>Boddicker</surname></persName>
							<affiliation key="aff12">
								<orgName type="department">Element Biosciences</orgName>
								<address>
									<postCode>10055</postCode>
									<settlement>San Diego</settlement>
									<region>CA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Junhua</forename><surname>Zhao</surname></persName>
							<affiliation key="aff12">
								<orgName type="department">Element Biosciences</orgName>
								<address>
									<postCode>10055</postCode>
									<settlement>San Diego</settlement>
									<region>CA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Bryan</forename><surname>Lajoie</surname></persName>
							<affiliation key="aff12">
								<orgName type="department">Element Biosciences</orgName>
								<address>
									<postCode>10055</postCode>
									<settlement>San Diego</settlement>
									<region>CA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Andrew</forename><surname>Altomare</surname></persName>
							<affiliation key="aff12">
								<orgName type="department">Element Biosciences</orgName>
								<address>
									<postCode>10055</postCode>
									<settlement>San Diego</settlement>
									<region>CA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Semyon</forename><surname>Kruglyak</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Shawn</forename><surname>Levy</surname></persName>
							<affiliation key="aff12">
								<orgName type="department">Element Biosciences</orgName>
								<address>
									<postCode>10055</postCode>
									<settlement>San Diego</settlement>
									<region>CA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Min</forename><surname>Yu</surname></persName>
							<affiliation key="aff3">
								<orgName type="department">Department of Stem Cell Biology and Regener ativ e Medicine</orgName>
								<address>
									<settlement>K</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Duane</forename><forename type="middle">C</forename><surname>Hassane</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Department of Physiology and Biophysics</orgName>
								<orgName type="department" key="dep2">Weill Cornell Medicine</orgName>
								<orgName type="institution">Cornell Univ ersity</orgName>
								<address>
									<postCode>10021</postCode>
									<settlement>Ne w York</settlement>
									<region>NY</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Susan</forename><forename type="middle">M</forename><surname>Bailey</surname></persName>
							<affiliation key="aff13">
								<orgName type="department">Department of Environmental and Radiological Health Sciences</orgName>
								<orgName type="institution">Colorado State University</orgName>
								<address>
									<postCode>80523</postCode>
									<settlement>Fort Collins</settlement>
									<region>CO</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
							<affiliation key="aff14">
								<orgName type="department">Cell and Molecular Biology Pr ogr am</orgName>
								<orgName type="institution">Color ado State University</orgName>
								<address>
									<postCode>80523</postCode>
									<settlement>Fort Collins</settlement>
									<region>CO</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Kelly</forename><surname>Bolton</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Jaime</forename><surname>Mateus</surname></persName>
							<affiliation key="aff5">
								<orgName type="institution">Space Exploration Technologies Corporation</orgName>
								<address>
									<addrLine>Ha wthorne</addrLine>
									<postCode>C A 90250</postCode>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Christopher</forename><forename type="middle">E</forename><surname>Mason</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Department of Physiology and Biophysics</orgName>
								<orgName type="department" key="dep2">Weill Cornell Medicine</orgName>
								<orgName type="institution">Cornell Univ ersity</orgName>
								<address>
									<postCode>10021</postCode>
									<settlement>Ne w York</settlement>
									<region>NY</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">The HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsaud Institute for Computational Biomedicine</orgName>
								<orgName type="institution">Weill Cornell Medicine</orgName>
								<address>
									<postCode>10021</postCode>
									<settlement>New York</settlement>
									<region>NY</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
							<affiliation key="aff15">
								<orgName type="institution">BioAstr a Inc</orgName>
								<address>
									<settlement>Ne w York</settlement>
									<region>NY</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
							<affiliation key="aff18">
								<orgName type="department">T he F eil Famil y Br ain and Mind Researc h Institute</orgName>
								<orgName type="institution">Weill Cornell Medicine</orgName>
								<address>
									<postCode>10021</postCode>
									<region>NY</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
							<affiliation key="aff19">
								<orgName type="department">WorldQuant Initiative for Quantitative Prediction</orgName>
								<orgName type="institution">Weill Cornell Medicine</orgName>
								<address>
									<postCode>10021</postCode>
									<settlement>New York</settlement>
									<region>NY</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff4">
								<orgName type="department">Sc hool of Medicine</orgName>
								<orgName type="institution">Univ ersity of Southern California</orgName>
								<address>
									<postCode>90033</postCode>
									<settlement>Los Angeles</settlement>
									<region>CA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Genome and clonal hematopoiesis stability contrasts with immune, cfDNA, mitochondrial, and telomere length changes during short duration spaceflight</title>
					</analytic>
					<monogr>
						<title level="j" type="main">Precision Clinical Medicine</title>
						<idno type="ISSN">2096-5303</idno>
						<idno type="eISSN">2516-1571</idno>
						<imprint>
							<publisher>Oxford University Press (OUP)</publisher>
							<biblScope unit="volume">7</biblScope>
							<biblScope unit="issue">1</biblScope>
							<date type="published" when="2024-04-08">8 April 2024</date>
						</imprint>
					</monogr>
					<idno type="MD5">56A9D058C1808CD7443EFEB15084B7F6</idno>
					<idno type="DOI">10.1093/pcmedi/pbae007</idno>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.8.2" ident="GROBID" when="2025-10-04T11:33+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<label type="revision">a91ee48</label>
					<label type="parameters">startPage=-1, endPage=-1, consolidateCitations=0, consolidateHeader=1, consolidateFunders=0, includeRawAffiliations=false, includeRawCitations=false, includeRawCopyrights=false, generateTeiIds=false, generateTeiCoordinates=[], sentenceSegmentation=false, flavor=null</label>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>genomes</term>
					<term>clonal</term>
					<term>hematopoiesis</term>
					<term>stability</term>
					<term>immune</term>
					<term>mitochondria</term>
					<term>ribosomes</term>
					<term>spaceflight</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p>Bac kground: The Inspir ation4 ( I4 ) mission, the first all-civilian orbital flight mission, in vestigated the ph ysiological effects of shortduration spaceflight through a multi-omic approac h. Despite ad vances, there remains muc h to learn about human adaptation to spaceflight's unique challenges, including micr ogravity, imm une system perturbations, and radiation exposure.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Methods:</head><p>To provide a detailed genetics analysis of the mission, we collected dried blood spots pre-, during, and post-flight for DNA extraction. Telomere length was measured by quantitative PCR, while whole genome and cfDNA sequencing provided insight into genomic stability and immune adaptations. A robust bioinformatic pipeline was used for data analysis, including variant calling to assess mutational burden.</p><p>Result: Telomere elongation occurred during spaceflight and shortened after return to Earth. Cell-free DNA analysis revealed incr eased imm une cell signatur es post-flight. No significant clonal hematopoiesis of indeterminate potential ( CHIP ) or whole-genome insta bility w as observ ed. The long-term gene expr ession changes acr oss imm une cells suggested cellular adaptations to the space environment persisting months post-flight.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conclusion:</head><p>Our findings provide valuable insights into the physiological consequences of short-duration spaceflight, with telomere dynamics and immune cell gene expression adapting to spaceflight and persisting after return to Earth. CHIP sequencing data will serve as a reference point for studying the early development of CHIP in astronauts, an understudied phenomenon as previous studies have focused on career astronauts. This study will serve as a reference point for future commercial and non-commercial spaceflight, low Earth orbit ( LEO ) missions, and deep-space exploration.</p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Introduction</head><p>Human spaceflight frequency has increased over the last decade, and with it, our grasp of its effects on human physiology. Despite this, there is much to learn about how humans adapt to the unique challenges of the space en vironment. T he space environment includes unique stressors, such as microgravity ( e.g. weightlessness ) , immune system perturbations, and space radiation exposure. Determining the effects of spaceflight on the human genome is imper ativ e to support long-term human presence in space. Additionally, a host of physiological adaptations occur when humans tr av el into space, r anging fr om cardiov ascular and musculoskeletal deconditioning, vision changes ( e.g. spaceflight associated neuro ocular syndrome ) , immune suppression, and metabolic changes, among others <ref type="bibr" target="#b0">[ 1 ]</ref>. Mor eov er, incr easing e vidence highlights the systemic immune dysregulation crewmembers experience from spaceflight exposure. Indeed, there appears to be a reduction in T cell fr equency, suppr essed cytotoxic function, as well as fluctuations in cytokine concentrations, with incr eased expr ession of TNF-α, interleukin-8, interleukin-1r a, thr ombopoietin, VEGF, and v arious c hemokines ( CCL2, CCL4, CXCL5, etc. ) associated with spaceflight <ref type="bibr" target="#b1">[ 2 ]</ref>.</p><p>To date, almost all space missions have been led by professional astr onauts fr om gov ernment space pr ogr ams. Mor e r ecently, ho w ever, SpaceX launched a crew of four civilian astronauts on the Inspiration4 ( I4 ) mission, marking a new era for human space exploration. The present I4 mission study aims to investigate the impact of short-duration spaceflight on civilians, along with the post-flight and long-term biomedical, immunologic, and genetic alterations resulting from spaceflight. This includes r a pid telomeric r esponses, wher eby telomer e elongation occurs as a function of spaceflight, follo w ed b y shortening upon return to Earth <ref type="bibr" target="#b2">[ 3 ]</ref>. Both unusually short and long telomeres have been associated with adverse health effects involving aging and a ge-r elated pathologies, suc h as cardiov ascular disease and cancer. Furthermor e, a v ariety of lifestyle factors and envir onmental exposures influence telomere length. Previous studies have also shown changes in clonal hematopoiesis, where a small number of hematopoietic stem cells ( HSCs ) gain a clonal adv anta ge thr ough the acquisition of somatic mutations. Clonal hematopoiesis is associated with cardiovascular disease, the de v elopment of acute m yeloid leuk emia ( AML ) , and incr eased ov er all mortality <ref type="bibr">[ 4 , 5 ]</ref>. The NASA Twins Study shed light on telomeric responses and the c hr onic inflammatory state resulting from long-duration spaceflight and provided the first measures of telomere length and clonal hematopoiesis in astronauts <ref type="bibr">[ 3 , 6 ]</ref>. Mutations in epigenetic r egulators, suc h as DNMT3A and TET2, were found at increased rates in both career astronaut twins when compared to their civilian counter parts. A r etr ospectiv e study of 14 astronauts who flew shuttle missions has also shown an ele v ated pr esence of genetic abnormalities in CHIP-driver genes in the astronaut population <ref type="bibr">[ 3 , 5 , 7 ]</ref>.</p><p>Here we investigated immune adaptations, telomere length dynamics, cell-fr ee DNA r elease, genomic stability, single-cell tr anscriptomic anal ysis, and bioc hemical ada ptations of the I4 cr e wmembers tr av eling into lo w er earth orbit over the course of 3 da ys , to determine the effects of short-duration spaceflight. It is imper ativ e to study these adaptations in this context for future space missions, as prolonged space envir onment exposur e could exponentiall y incr ease the r ate of m utational burden <ref type="bibr" target="#b7">[ 8 ]</ref>, be it due to the inflammatory milieu r esulting fr om spaceflight or the particular challenges of the space environment, such as microgravity and radiation exposure . Here , we leveraged the I4 mission to examine the de v elopment of genetic abnormalities in the astronauts by studying their physiological response to the demands of spaceflight and quantifying the genetic changes that are associated with spaceflight.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Methods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Informed consent and ethics</head><p>This study was completed following a ppr opriate ethical guidelines according to the Declaration of Helsinki, ICHGCP, and local regulations, as applicable, from each potential subject or each subject's legally authorized re presentati ve prior to participating in the r esearc h study. The pr otocol, the ICF, other written material given to the patients, and any other r ele v ant study documentation were submitted to and a ppr ov ed by the a ppr opriate ethics committee . T his study was conducted under a protocol reviewed and a ppr ov ed by the a pplicable ethics committees and investigations were undertaken by scientifically and medically qualified persons, where the benefits of the study were in proportion to the risks. All subjects were consented at an informed consent briefing ( ICB ) at SpaceX ( Ha wthorne , C A ) , and samples were collected and processed under the approval of the Institutional Re vie w Board ( IRB ) at Weill Cornell Medicine, under Protocol 21-05023569. All cr e w members provided written informed consent for data and sample sharing.</p><p>I4 launc hed fr om K ennedy Space Center's Launc h Complex 39A and tr av eled into Low-Earth Orbit acr oss a thr ee-day mission, r eac hing an orbital altitude of a ppr oximatel y 364 miles and ultimately splashed down into the Atlantic Ocean.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Dried blood spot ( DBS ) pre-flight, in-flight, and post-flight sampling</head><p>Cr e w members warmed and massaged their fingertips to maximize blood flow. Fingertips were sterilized ( BZK antiseptic towelette, Dynarex, Reorder No. 1303 ) and punctured using a contactactivated lancet ( BD Biosciences, #366 593 ) or a 21-gauge needle ( BD Biosciences, #305 167 ) . Whatman 903 Protein Saver DBS cards ( Cytiv a, #10 534 612 ) wer e used to ca ptur e, tr ansfer, and then store capillary blood with a desiccant pack ( Cytiva, #10 548 239 ) at ambient temper atur e.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>DN A extr action for qPCR-based assessment of telomere length</head><p>Three 3 mm circular punches were cut from the Whatman 903 Pr otein Sav er Cards ( cat# WHA10534612 ) containing blood samples using an Integra Miltex Standard Biopsy Punch ( cat# 12-460-406 ) and placed into a 1.5 mL microcentrifuge tube with sterile tw eezers. Samples w er e pr epar ed using the Qia gen QIAamp DNA Investigator Kit ( cat# 56 504 ) following the manufacturer's isolation of total DNA from FTA and Guthrie Cards protocol. The quantification of DNA in each sample was determined through fluorometric quantification with the Qubit 4 Fluorometer ( Thermo Fisher Scientific, cat# Q33238 ) and the 1X dsDNA HS Assay Kit ( cat# Q33231 ) . DN A samples w er e sent to Color ado State Univ ersity for multiplex qPCR analysis.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Multiplex quantitati v e PCR telomere length measurement</head><p>MMqPCR measurements of telomere length were carried out by preparing 22 μL of master mix using SYBR green Go-Taq qPCR master mix ( Promega #A6001 ) combined with the telomere forw ar d primer ( TelG; 5 -A CA CTAA GGTTTGGG TTTGGGTTTGGGTTTGGGTTAGTGT-3 ) , telomer e r e v erse primer ( T elC; 5 -TGTT AGGT A TCCCT A TCCCT A TCCCT A TCCCT A TCC CT AACA-3 ) , albumin forw ar d primer ( AlbU; 5 -CGGC GGCGGGCGGCGCGGGCTGGGCGGA AATGCTGC AC AGAATCCTTG-3 ) , albumin r e v erse primer ( AlbD; 5 -GCCCGGCCCGC CG 4 CGCCCGTCCCGCCGGAAAAGCATGGTCGCCTGTT-3 ) at 10 μM per primer ( Integr ated DNA Tec hnologies ) , and RNase/DNase free water. Then 3 μL of DNA at 3.33 ng/uL was added for a final volume of 25 μL, final TelG/C primers concentration of 900 nM, and the AlbU/D primers at 400 nM. A Bio-Rad CFX-96 qPCR machine was used to measure telomere length. The cycle design w as as follo ws: 95</p><p>• C for 3 min; 94 • C for 15 s, 49 • C for 15 s, for 2 cycles; 94 • C for 15 s, 62 • C for 10 s, 74 • C for 15 s, 84 • C for 10 s, and 88 • C for 15 s, for 32 cycles. The melting curve was established by a 72 • C to 95 • C ramp at 0.5 • C/second increase with a 30 second hold. Standard curves were prepared using human genomic DNA ( Promega Cat # G3041 ) with 3-fold dilutions ranging from 50 ng to 0.617 ng in 3 μL per dilution. Negativ e contr ols included a no-template TelG/C only and AlbU/D only, and a combined TelG/C and AlbU/D contr ol. Samples wer e normalized across plates using a human genomic DN A standar d. Each sample was run in triplicate on a 96-well plate format and r elativ e telomer e length was established using a telomere ( T ) to albumin ( A ) ratio.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Whole genome extraction and sequencing</head><p>Genomic DN A w as obtained from the cell pellet of a cell-free DNA blood collection tube ( Str ec k, cat# 230470 ) using the QI-Aamp Blood Maxi Kit ( Qiagen, cat# 51192 ) , and then shipped to Element Biosciences for library preparation. The extracted DNA was quantified using Thermo Fisher Qubit dsDNA HS Assay Kit ( cat# Q238253 ) and 8 samples wer e pr epar ed using the KAPA Hy-perPrep Kit and KAPA Unique-Dual Indexed Adapter Kit ( cat# 8 861 919 702 ) . The DNA libraries were quantified using Thermo Fisher Qubit dsDNA HS Assay Kit ( cat# Q32854 ) and sized using Agilent High Sensitivity DNA Kit ( cat# 5067-4626 ) .</p><p>The 8 DNA libraries generated with the KAPA HyperPrep Kit wer e pr ocessed using Adept Library Compatibility Kit ( Element Biosciences, Cat# 830-00003 ) , individually circularized with 0.5pmol ( 30 μL of 16.67nM ) input, and quantified using the kitprovided qPCR standard and primer mix. The libr aries wer e pooled into 4 separate 2-plex pools, each denatured and sequenced on Element AVITI system ( Element Biosciences, Part #88-00 001 ) using 2 × 150 paired end reads with indexing. Primary analysis was performed onboard the AVITI sequencing instrument.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>W hole genome/cfDN A preprocessing</head><p>Blood and plasma samples were subjected to whole genome and cfDNA short read sequencing as detailed abo ve . Resultant FASTQ files wer e v alidated using FastQC ( v0.11.9 ) and MultiQC ( v1.13 ) . Read adapters were trimmed at 3 and 5 ends for low quality using Trim Galore ( v0.6.5 ) , lo w er quality reads were classified and r emov ed, r etaining onl y those r eads with length &gt; = 25bp, and ph read quality &gt; = 20. Reads were aligned against the hg38 human r efer ence genome with BWA MEM ( v.0.7.15 ) and subjected to standard QC and deduplication pr ocedur es as a part of Sentieon's TNscope ( v202010 ) DN Aseq w orkflo w <ref type="bibr" target="#b8">[ 9 ]</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>W hole genome/cfDN A/single cell v ariant calling</head><p>Aligned and pr epr ocessed r eads wer e subjected to the TNScope variant calling pipeline. Calls were filtered using Fisher's exact test and subsetted to SNP variants using samtools ( v1.16.1 ) , and filtered by triallelic sites, short tandem repeats, read quality, and read position bias using BCFtools ( v1.16 ) . Varient-Effect-Predictor VEP ( v107 ) was utilized for annotation of variants and further filtering based on predicted impact of mutations. Resulting coordinates wer e pr ocessed into allele and gene frequency matrices, and visualized in R using the tidyverse ( v1.3.2 ) suite of packages.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>cfDN A extr action and sequencing</head><p>cfDN A w as isolated from 500 μL aliquots of plasma from cfDNA blood collection tubes ( Str ec k, #230470 ) . cfDN A w as extracted fr om eac h cr e w member fr om all timepoints ( 4 cr e w members, 6 timepoints, 24 total extractions ) . cfDN A w as extracted using Qiagen's QIAamp ccf DN A/RN A Kit and eluted in 15 μL Qiagen Elution Buffer per sample. Yield was measured for each sample using Thermo Fisher Qubit 1X dsDNA HS Assay ( cat# Q33231 ) .</p><p>Entir e extr act v olume w as used as input for libr ary pr epar ation using NEBNext Ultra II DNA Library Preparation Kit for cfDNA protocol. Each sample w as bar coded using NEBNext Multiplex Oligos for Illumina ( Unique Dual Index UMI Ada ptors-96 r eactions ) . Final library was eluted in 30 μL and checked for concentration using Thermo Fisher Qubit 1X dsDNA HS Assay ( cat# Q33231 ) . Fr a gment sizes were determined using Agilent's Tapestation 2100 and D1000 r ea gents and Scr eenTa pe, with r esulting av er a ge fr a gment size ∼380 bp ( 0.25 pmol ) of each sample.</p><p>A total of 24 cfDNA libraries generated with the NEBNext Ultra II DNA Libr ary Pr epar ation kit wer e pr ocessed using Adept Libr ary Compatibility Kit ( Element Biosciences, Cat# 830-00003 ) . Each library w as cir cularized individually with an input range of 0.2-0.5 pmol ( 30 μL of 6.67-16.67nM ) based on linear library yields . T he final circularized libraries were quantified using qPCR standard and primer mix and pooled into 2 separate 4-plex pools. Each 4plex pool was denatured and sequenced on Element AVITI system ( Element Biosciences, Part #88-00001 ) using 2 × 147 paired reads with 19 bp UMI/index 1 and 8 bp index 2. Primary analysis was performed onboard the AVITI sequencing instrument.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Clonal hematopoiesis targeted variant calling</head><p>Genomic DN A w as obtained from the cell pellet of a cell-free DNA blood collection tube ( Str ec k, cat# 230 470 ) using the QIAamp Blood Maxi Kit ( Qiagen, cat# 51 192 ) . All samples from the testing and validation cohort were sequenced using a custom designed DNA sequencing assay ( DB0188, VariantPlex, ArcherDX ) . This panel ca ptur es the nine genes most commonly mutated in solid tumor patients following ther a peutic r adiation including the full exonic regions of five genes ( DNMT3A, TET2, ASXL1, TP53, CHEK2 ) and targeted exonic regions of four genes ( JAK2, SRSF2, SF3B1, PPM1D ) . Libr aries wer e pr epar ed fr om 250 ng gDNA using the VariantPlex protocol ( ArcherDx Inc., Boulder, CO, USA ) which utilizes Anc hor ed Multiplex PCR ( AMP ) tec hnology to gener ate tar get-enric hed sequencing-r eady libr aries. Follo wing DN A fr a gmentation ligation with a universal ArcherDx molecular barcode ( MBC ) adapter is performed, which tags each DNA molecule with a unique molecular index ( UMI ) and allows for unidirectional amplification of the sample using gene-specific primers . T he resulting libraries were sequenced using a NovaSeq 6000 instrument ( Ilumina ) , as per manufacturer's instructions . T he methods for variant identification are comparable to those in Novetsky et al. 2023 <ref type="bibr" target="#b9">[ 10 ]</ref>. The variant calling pipeline included UMI consensus building follo w ed b y utilizing Mutect2, VarDictJ av a, Lofr eq2, Pindel in parallel for variant identification. Normalization was performed via LeftTrimAndAlign, and a panel of normals of 27 children and young adults was used with a bonferr oni-corr ected p value to identify true putative mutations in our astronaut cohort. A pileup analysis as performed in Bolton et al. 2020 <ref type="bibr" target="#b10">[ 11 ]</ref> was used to query variants in longitudinal follow-ups. A variant list was used to scrutinize raw BAM files and the P oN samples , a fisher's exact test and Bonferr oni-corr ected p v alue wer e used to determine a noise threshold. Variants surpassing this threshold in at least one sample were further examined in the remaining samples, and if statistically validated, the variants were aggregated to construct the final v ariant list. Variant-Effect-Pr edictor VEP ( v107 ) and SnpEff ( v4.3 ) was used for annotation of variants. Data wrangling, tidying, and visualizations were performed using R ( v4.1.2 ) , Rstudio ( v2021.09.2 ) and libraries ( Tidyv erse, Dpl yr, data.table, ggplot2 ) .</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>cfDN A fr agment anal ysis</head><p>Fr a gment size distribution was calculated using the bamPEFr a g-mentSize tool from the deepTools Python package ( v3.5.1 ) . Levels of cfDNA ( read counts ) originating from different chromosomes were normalized by c hr omosome length and total number of reads in the library generating a Read per Kilobase per Million r eads ( RPKM ) measur ement. The fr action of cell-fr ee mtDNA r elativ e to c hr omosomal cfDN A in plasma w as compared and visualized in R using the tidyverse ( v1.3.2 ) suite of packages.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>cfDNA tissue of origin deconvolution</head><p>The enrichment of cfDNA fragments from various tissues was calculated by read coverage depletion analysis at transcription starting sites ( TSSs ) to estimate nucleosome positioning and infer gene expression. The pipeline is described in detail in Bezdan et al. 2020 <ref type="bibr" target="#b6">[ 7 ]</ref>. The resulting nucleosome periodicity was correlated with ( 1 ) per-tissue gene expression reference matrix retrieved from the Human Pr oteome Ma p ( HPM; Kim et al. 2014 <ref type="bibr" target="#b11">[ 12 ]</ref> ) or ( 2 ) individual astronaut pseudo-bulk expression of different cell subpopulations extr acted fr om PBMC scRNAseq dataset. In both cases the tissue/subpopulation-periodicity correlations were ranked by the value of Pearson's correlation coefficient, clustered ( utilizing Ward method with Euclidean distances ) and visualized in R using the tidyverse ( v1.3.2 ) and ComplexHeatmap ( v2.14.0 ) packages.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Single-cell gene expression analyses</head><p>Longitudinal single cell data was processed in R using the Seur at pac ka ge ( v4.3.0 ) to normalize, scale and cluster cell populations. Cell identities were determined through computational gating parameters of inclusion based on gene expression of k e y mark ers, similar to gating from Fluorescent-Activated Cell Sorting. CD8 + T cells were selected from the PBMC population by filtering CD3D + CD8A + positive cells. CD4 + T cells from CD3D + CD8A + cells, CD14 + monocytes from CCR2 + CD14 + cells, CD16 + monocytes from CD14 + CD16 + cells, NK cells from NCAM1 + CD3-and NCR3 + CD3-cells and DCs from CD86 + , CD83 + cells.</p><p>The Seur at pac ka ge ( v4.3.0 ) was used for normalization, scaling, and differential gene expression analysis of sn-RNA data. Data wrangling, tidying, and visualizations were performed using R ( v4.1.2 ) , RStudio ( v2021.09.2 ) and libraries ( Tidyv erse, Dpl yr, data.table, ggplot2 ) .</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Telomere length measurement ( MMqPCR )</head><p>We first examined DNA from dried blood spots ( DBS ) , which were collected from the I4 crew members before ( L-92, L-44, L-3 ) , during ( FD1, FD2, FD3 ) , and after ( R + 1, R + 45, R + 82 ) spaceflight, from which DN A w as isolated, and telomer e length measur ed via m ultiplexed quantitative PCR ( MMqPCR ) ( Fig. <ref type="figure" target="#fig_0">1 A</ref> ) . Telomere elongation was observed in all four I4 cr e wmembers during spaceflight, as compared to their pre-and post-flight normalized means ( Fig. <ref type="figure" target="#fig_0">1 A</ref> ) . Telomere length shortened rapidly upon return to Earth in 3 of the 4 astronauts ( post-flight ) , and overall continued to shorten over the course of the recovery period. Repeated-measurements ANOVA was performed on the data to assess the ov er all impact of time on telomere length. Post hoc pairwise comparisons identified pre-flight vs in-flight ( P &lt; 0.001 ) and pre-flight vs R + 1 ( P &lt; 0.02 ) as timepoints between which significant differences in telomere length occurred.</p><p>Intriguingly, despite the short duration of the I4 mission ( 3 days of orbital flight ) , these results correlated with findings from the NASA Twins Study ( One Year Mission astronaut ) , as well as with astronauts on ∼6 month missions onboard the International Space Station ( ISS ) <ref type="bibr">[ 3 , 13 ]</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Cell-free DNA</head><p>Next, cell-free DN A ( cfDN A ) from the I4 crew's plasma was extr acted fr om Str ec k Cell-fr ee DNA BCT tubes and sequenced to compar e to pr e-flight baseline, post-flight, and r ecov ery period r esponses. Extraction and pre-processing of plasma were not implemented during the flight, so all samples were collected on Earth to mitigate cfDNA contamination from apoptotic blood cells during sample transportation ( Supplememtary Fig. <ref type="figure" target="#fig_0">S1A</ref> &amp; B, see online supplementary material ) <ref type="bibr" target="#b7">[ 8 ]</ref>. We analyzed plasma mitochondrial cfDN A ( cf-mtDN A ) r elativ e to the c hr omosomal cfDNA fr action ( Fig. <ref type="figure" target="#fig_0">1</ref> B &amp; C, S upplememtary Table <ref type="table">S3</ref> , see online supplementary material ) as a potential biomarker for long-duration spaceflight ada ptations. In this mission, cf-mtDNA le v els did not rise significantly following the return to Earth ( R + 1 ) , possibly due to the short flight dur ation. Cf-mtDNA enric hment was onl y observ ed in the twin astronauts on the ISS after months of exposure to the space en vironment. T he marker le v els display high betweensample heterogeneity, and the increase in pre-flight measurements may be connected to the I4 cr e w's pr e-flight pr epar ation ( e.g. high-altitude training ) .</p><p>Giv en that cfDNA fr a gments encompass one nucleosome ( ∼150 bp ) , we inspected depletion in read coverage distribution around the transcription start sites ( TSS ) as a measurement of gene expr ession <ref type="bibr">[ 6 , 14 ]</ref>. We a pplied cov er a ge normalization specific to the genomic neighborhood and completed Fourier transformation to determine nucleosome footprints based on signal periodicity <ref type="bibr" target="#b6">[ 7 ]</ref>. The cfDNA fr a gment tissue and cell-type-of-origin enric hment of fr a gments wer e corr elated with either tissue-specific expression signatur es fr om the Human Pr oteome Ma p ( HPM ) <ref type="bibr" target="#b11">[ 12 ]</ref> or individual astr onaut expr ession pr ofiles fr om peripher al blood <ref type="bibr" target="#b14">[ 15 ]</ref> ( Fig. <ref type="figure" target="#fig_0">1</ref> D &amp; E, S upplememtary Fig. <ref type="figure" target="#fig_0">S1C</ref> , S upplememtary Tables S1 &amp; S2 , see online supplementary material ) . The most r epr esented sequences were of hematopoietic origin, while a small increased pr esence of cfDNA fr a gments fr om both innate and ada ptiv e immune cells was observed post-landing and during the recovery period. Inter estingl y, ther e was a significant increase in the cfDNA originating from all immune cells in all astronauts over a month following their return to Earth ( R + 82 ) , indicating a degree of heterogeneity in cell lysis over time and a possible long-term response.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Clonal hematopoiesis of indeterminate potential ( CHIP ) assessment</head><p>While CHIP has been pr e viousl y studied in astronauts, the I4 cohort provided an opportunity to study the physiological impact  <ref type="table">S1</ref> , see online supplementary material. ( E ) Cross-examination of cfDNA origin deconvolution using each of I4 astronaut cell-subpopulation-specific expression mark ers, deri ved from peripheral blood ( PBMC ) dataset, supports the results in D. We note an incr eased pr esence of innate and ada ptiv e imm une cfDNA in R + 1 and R + 82 when compar ed to all other timepoints . T he extended data is a vailable in S upplememtary Tables S2 , see online supplementary material.</p><p>of spaceflight in a civilian cr e w that had ne v er under gone orbital flight. Indeed, the monitoring of this cr e w pr ovides us with a unique opportunity to understand the beginning of the already established relationship between career astronauts and CHIP. Of note, the NASA Twins Study assessed the mutational burden of long-duration spaceflight in CHIP genes and a retrospective study established a burden of CH-related mutations in the career astronaut population <ref type="bibr">[ 3 , 4 ]</ref> and we sought to examine these same CHIP genes for the I4 cr e w . T o address the variant allele frequency ( VAF ) of CHIP genes, we performed deep targeted sequencing ( &gt; 15,000x ) of 10 known epigenetic regulators and CHIP-associated genes and assessed the mutational burden of short duration spaceflight in the I4 astronaut cohort. Notably, the mutational burden of the CHIP-associated genes did not change as a function of spaceflight and remained stable for up to 6 months post spaceflight ( Fig. <ref type="figure" target="#fig_1">2 A</ref> ) . No known deleterious mutations arose in the I4 cohort post-flight, nor did an y pr e-existing somatic mutations increase in allele frequency significantly ( Fig. <ref type="figure" target="#fig_1">2 B</ref> &amp; <ref type="figure">C</ref> ) . Putati ve dri ver mutations were found in two out of the four astronauts but their VAF remained comparable at all timepoints, indicating stability of the VAF from the spaceflight.</p><p>To give context for these data, we next collected additional samples for both subjects in the NASA Twins Study. Subject TW ( long duration spaceflight ) presented mutation TET2.p.Cys1273Tyr in a bulk PBMC sample at an increased VAF of ∼ 0.075 ( Fig. <ref type="figure" target="#fig_1">2 D</ref> ) . Subject HR ( ground control ) presents the mutation DNMT3A.p.Trp698Ter at an increased VAF of ∼ 0.086 and the mutation DNMT3A.p.Asp856Gly not previously found at a VAF of ∼ 0.05 ( Fig. <ref type="figure" target="#fig_1">2 E</ref> ) . Both astronauts presented increased clonality when compared to previous timepoints . T heir mutational burden was still greater than a ge-matc hed contr ols, as established in the original study. Ho w e v er, the incr eased m utational burden is an expected finding, given the association between aging and CHIP <ref type="bibr" target="#b15">[ 16 ]</ref> and there's no evidence of them having any clinical effects to date.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Longitudinal comparison of whole genome muta tions re veals genomic stability months after short-dur a tion orbital flight</head><p>To assess the long-term consequences of spaceflight on the genomic stability of astronauts, we conducted whole-genome sequencing ( WGS ) and variant calling pre-and post-flight. Comparison of single nucleotide variant ( SNV ) and indel presence between timepoints ( L-44 and R + 45 ) for each astronaut indicated no significant changes for genes with the highest mutational burden ( Fig. <ref type="figure" target="#fig_2">3 A</ref> ) , epigenetic regulator genes ( S upplememtary Fig. <ref type="figure" target="#fig_2">S3</ref> , see online supplementary material ) or other gene sets of interest. The analysis of variant annotations ( Fig. <ref type="figure" target="#fig_2">3 A</ref> &amp; <ref type="figure">C</ref> ) revealed that most identified variants are within intronic regions and have no significant effects. We also have noted no disproportional mutational load for variants post-flight ( Fig. <ref type="figure" target="#fig_2">3 D</ref> ) . We performed variant calling in single nucleus RNA-seq ( snRNA-seq ) libr aries and compar ed it across all timepoints and against WGS for genes with read cover a ge &gt; 10x ( S upplememtary Fig. <ref type="figure" target="#fig_2">S3</ref> B &amp; C, see online supplementary material ) . Whole genome cov er a ge of the snRNA-seq libraries v aried br oadl y acr oss timepoints, but did not show any significant evidence of genomic instability within our cohort.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Spaceflight induces cell-type-specific changes in gene expression profiles</head><p>We next examined gene expression changes across immune cell types due to spaceflight. Cell type-specific genes were used to fil-ter cell types computationally. CD8 + T cells, and CD4 + T cells, CD14 + monocytes, CD16 + monocytes, dendritic cells ( DCs ) and natural killer ( NK ) cells were filtered from PBMCs at six different timepoints: L-92, L-44, L-3, R + 1, R + 45, and R + 82.</p><p>Gene expression of CD8 + T cells at R + 1 and R + 82 sho w ed incr eased expr ession of genes r elated to imm une function, ribosomal and mitochondrial activity ( e.g. NKG7, CCL5, HLA-C, S100A4, RPL41, RPS11, MT-CO3, PTMA, B2M , see Fig. <ref type="figure" target="#fig_3">4 B</ref> ) . Similar tr ends wer e seen with CD14 + monocytes , DCs , CD4 + , FCGR3A + monocytes , NK cells, and CD3D + cells ( S upplememtary Fig. <ref type="figure" target="#fig_3">S4</ref> C &amp; D, see online supplementary material ) . Increased gene expression of mitochondrial and ribosomal genes was conserved across cell types for both L-92 vs R + 1 and L-92 vs R + 82 comparisons. PLCG2, MTRNR2L12, VCAN, and MAML2 transcripts associated with imm une function, mitoc hondrial function, cell adhesion, and Notc h signaling wer e consistentl y downr egulated acr oss all cell types ( Fig. <ref type="figure" target="#fig_3">4</ref> &amp; S upplememtary Fig. <ref type="figure" target="#fig_3">S4</ref> ) .</p><p>Inter estingl y, the pr oportion of cells expr essing these genes does not necessarily change in parallel with total gene expression le v els . For example , PLCG2 expression, on a per cell basis, decreased, but the total proportion of cells expressing PLCG2 increased among CD8 + T cells at R + 1 ( 0.98 ) vs. L-92 ( 0.81 + /-0.07 s .e . ) and R + 1 vs. R + 82 ( 0.66 + /-0.04 s .e . ) , classical monocytes at R + 1 ( 0.99 ) vs. L-92 ( 0.96 + /-0.01 s.e. ) and R + 1 vs. R + 82 ( 0.92 + /-0.05 s .e . ) as well as DCs at R + 1 ( 0.99 ) vs. L-92 ( 0.96 + /-0.01 s .e . ) and R + 1 vs . R + 82 ( 0.92 + /-0.04 s .e . ) ( Fig. <ref type="figure" target="#fig_3">4 A</ref>, <ref type="figure">C</ref> &amp; <ref type="figure">E</ref> ) . Gene expression of mitochondrial cytochrome c oxidase, particularly subunits 2 and 3 ( MT-CO2 &amp; MT-CO3 ) , incr eased acr oss all cell types, per cell, for R + 1 compared to L-92 and R + 82, with no significant change in the proportion of cells expressing these genes. MTRNR2L12 expression was consistently decreased across all studied cell types for R + 1 vs. L-92 but gr eatl y incr eased for R + 82 vs. L-92 and R + 82 vs. R + 1, suggesting changes in gene expression lasting over two months post-flight in both adaptive and innate immune cells.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion</head><p>The I4 mission is the first study to date to analyze the effect of short duration spaceflight on civilians using a compr ehensiv e m ulti-omics a ppr oac h. Our findings, including telomer e length dynamics, CHIP-related clonal expansion, WGS genomic stability, cfDNA cell lysis analysis, and immune cell longitudinal gene expr ession pr ofiling, br oadl y contextualize the physiological burdens of short duration spaceflight. This study adds key CHIP and genetic data on astr onauts, whic h ar e limited, and can serve as a r efer ence for futur e spaceflight planning, short missions around Earth's orbit, and longer-duration missions into deep space.</p><p>The NASA Twins Study was the first to report spaceflightspecific telomere elongation in humans, with one astronaut experiencing telomere elongation during his one-year mission, rapid telomere shortening upon return to Earth, and telomere length r ecov ery to near pre-flight baseline values over the following months, although many more short telomeres after spaceflight than befor e wer e also observ ed <ref type="bibr" target="#b2">[ 3 ]</ref>. Luxton et al. reported similar spaceflight-associated telomere length dynamics in 3 unrelated astronauts on ∼ 6-month missions onboard the ISS <ref type="bibr" target="#b12">[ 13 ]</ref>. It was hypothesized that such dramatic shifts in telomere length dynamics were associated with c hr onic exposur e to the space radiation envir onment and r epr esented an ada ptiv e r esponse to c hr onic oxidativ e dama ge, specificall y to telomer es, wher eby the alternativ e lengthening of telomeres ( ALT ) pathway is transiently activated in normal somatic cells <ref type="bibr" target="#b12">[ 13 ]</ref>. Cytogenetic evidence of heterogeneous  Comparison of variant consequences before and after spaceflight of genes with the greatest mutational burden demonstrates no gene is disproportionately mutated post-flight. We report unique counts of ( variant, effect annotation ) pairs per gene of interest. ( B ) De novo mutational comparison elucidates comparable mutational burdens at a genome-wide scale. Here we count variants as unique changes of reference to alternative alleles at a given position regardless of variant annotation. ( C ) Variant effect annotation for variants called in both timepoints shows most mutations are in non-coding regions. Variant annotations were ranked according to the se v erity of the v ariant effect estimated by Ensembl <ref type="bibr" target="#b14">[ 15 ]</ref>. We report unique counts of ( variant, effect annotation ) pairs across the whole genome. ( D ) Timepoint comparison of variant effect annotations across the whole genome shows no disproportional mutational load for variants called uniquely post-flight. Here we show the distribution for moderate to high-severity variants.</p><p>telomere lengths and DNA damage responses were also reported, and-together with our cfDNA enrichment analyses-suggested incr eased DNA dama ge and ar e consistent with space r adiation exposure and increased senescence-associated foci. Similar changes in telomere length dynamics observed in the I4 crew as a function of spaceflight indicate that telomere length alterations are fast-acting as associated with spaceflight, even for missions of short ( e .g. da ys ) dur ation. Circulating cell-fr ee DNA ( cfDNA ) fr a gments, originating fr om v arious tissues and the immune system, offer a non-inv asiv e method for assessing astronauts' dynamic imm une r esponses to spaceflight-induced physiological str ess. As an emerging biomarker, cfDNA concentration and molecular profile yield valuable insights into stress responses in unique spaceflight environments despite its heterogeneous and sensitive nature.</p><p>Our study indicates that the impact of short-duration spaceflight on cfDNA concentration in astronaut plasma is subtler than long duration missions, but increased innate and adaptive immune system activity is still apparent. Moreover, cfDNA enrichment from all immune cells persists post-flight, suggesting a dela yed response in volving immune cell turnover and active DNA r epair mec hanisms . T his phenomenon warrants further in vestigation as it is imper ativ e for both short and long duration spaceflight to elucidate the temporal changes to immune cell types in order to better predict and prevent future risks.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Effects of short and long dur a tion spaceflight on CHIP genomic alter a tions in civilian and career astronauts</head><p>In the I4 cohort, we found no relationship between spaceflight and increased CHIP-related genetic abnormalities in the scale of three months after spaceflight. With our deep sequencing targeted probe approach ( Mean Depth ∼15,000x ) , we found putativ e m utations pr esent in subject C004's and C003 targeted samples but not C001 and C002. DNMT3A gene mutations chr2: g.25235778C &gt; G, chr2: g.25234347G &gt; C, chr2: g.25241591C &gt; A are all missense variants with a likely low/moderate impact on function. A frameshift mutation, chr2: g.25246732GTCGTGGC AC ACCGGGAAC AGCTTCCCCGC &gt; G, was detected in astronaut 004, as well as a stop-gain function mutation chr2: g.25247647G &gt; A. Although DNMT3A presented the higher number of mutations, CHEK2 presented a missense mutation chr22: g.28734438C &gt; T in C004, and ASXL1 presented a fr ameshift m utation c hr20: g.32434638AG &gt; A in both C003 and C004. Ho w e v er, with a VAF of &lt; 0.02 for all timepoints, although detectable, there is no evidence to suggest a clinical effect on the subjects , that is , spaceflight ha ving no discernible effects up to 3 months post-flight. TET2 exhibited a missense mutation chr4: g.105275662G &gt; T at a VAF ∼ 0.3 in C003. Ho w e v er, putativ e m utations in CH-linked genes were not found at disproportionate allele frequencies post-flight, nor were de novo mutations seen in the post-flight samples.</p><p>Although our findings suggest that no pathological genomic alter ations occurr ed as a function of spaceflight in the I4 cohort, further longitudinal tr ac king of the astronauts will help us discern the long-term effects, if any, of short dur ation missions. Pr e vious studies of the relationship between clonal hematopoiesis and astronauts has elucidated that spaceflight incr eases pr oportion of CH abnormalities in subjects when compared to healthy controls <ref type="bibr">[ 3 , 4 ]</ref>. It is not clear why that is the case, or when in an astronaut's career these abnormalities begin to appear, a k e y limitation of studying career astronauts. Previous studies have also shown the influence of acute e v ents on the de v elopment of CH abnormalities, such as first responders from the world trade center tragedy <ref type="bibr" target="#b16">[ 17 ]</ref>. Ther efor e, the I4 mission is uniquely positioned to characterize the clonal dynamics associated with a short-duration flight, and will allow future comparisons between career astronaut CH abnormalities and civilian space tr av elers. Ther e is an opportunity to study the compound effects of spaceflight between missions on CH abnormalities if one or more of the I4 astr onauts r eturns to space . T his can be le v er a ged for a better understanding of longterm risk and clonal evolution.</p><p>The space environment is known to be chronically inflammatory as astronauts in previous studies have reported increased inflammation markers with the flight duration <ref type="bibr" target="#b17">[18]</ref><ref type="bibr" target="#b18">[19]</ref><ref type="bibr" target="#b19">[20]</ref>. In the NASA Twins Study, both career astronauts had increased mutational burden in epigenetic regulators such as DNMT3A and TET2 compared to prostate cancer patient controls. Although only one of the twins was in orbital spaceflight for a year, both twins displayed comparable CHIP-related mutations shortly after flight and for se v er al years of follow-up <ref type="bibr" target="#b5">[ 6 ]</ref>. We continue to monitor the CHIP-related mutational burden of both astronauts years post-flight. The VAF of mutations found in both subjects has, as expected, incr eased ov er time, and a new missense variant has been identified in subject HR in the last 3-year followup. This is to be expected as CHIP-mutational burden is known to increase as a function of aging. Both astronauts, ho w ever, presented clonal burdens that preceded their age-matched control for over two decades at the time of the original study. The fact that TW ( space subject ) did not present a greater mutational burden post-flight than HR ( ground control ) , despite the length of his last mission, might indicate that the ov er all number of flights, rather than their duration, is a greater extrinsic factor for clonal positive selection. The I4 cohort provides a unique opportunity to assess the short and long term physiological effects of a singular spaceflight mission. As civilians, the I4 cohort's physiological findings are likely a better representation of what first-time fliers may expect as we gear up toward an increased human presence in space.</p><p>Mor eov er, the longitudinal comparison of point mutations and indels from whole-genome sequencing data supports the results of the targeted deep-sequencing CHIP panel, wher ein ther e is not a significant increase in the genome-wide mutational burden for first-flight civilian astronauts . T hese results favorably indicate that short-time spaceflight does not contribute to ov er all increased genomic instability, at least on a timescale of se v er al months post-flight. Extending the analysis to future missions and continuous longitudinal tr ac king for years post-flight could shed more light on the long-term consequences of spaceflight in relation to its altitude and duration, or for low VAF alleles, as well as r epeated exposur e of astr onauts to space r adiation.</p><p>Finally, we note that transient changes in mitochondrial gene expr ession wer e seen as a r esponse to spaceflight acr oss a br oad range of immune cells within the I4 cohort. Longitudinal gene expr ession anal yses r e v ealed a conserv ed tr end acr oss both ada ptive and innate immune cells that had not been described before in the spaceflight liter atur e. In comparisons between L-92 vs R + 1 and R + 1 vs R + 82 all immune cell types demonstrated incr eased expr ession of MTRNRL12, MTRNR2L8, and MT-ND4L in R + 1. MTRNRL12 and MTRNR2L8 are pseudogenes thought to be involved in negative regulation of the execution phase of apoptosis <ref type="bibr" target="#b20">[ 21 ]</ref>. As suc h, incr eased MTRNRL12 &amp; MTRNR2L8 expression could indicate a physiological attempt at r egulating incr eased imm une cell death. Incr eased imm une cell apoptosis was seen in our cfDNA analysis, at all post-flight timepoints, providing support to the gene expression alterations seen.</p><p>Of note, MT-CO2 and MT-CO3 gene expr ession wer e downr egulated post-flight ( R + 1 ) compared to pre-flight ( L-92 ) within CD86 + DCs , NC AM + NK cells , CD14 + monocytes , and CD3 delta + CD8 + &amp; CD4 + T cells ( Fig. <ref type="figure" target="#fig_3">4 B</ref>, <ref type="figure">D</ref>, <ref type="figure">F</ref> &amp; s upplememtary Fig. <ref type="figure" target="#fig_3">S4 B</ref>, <ref type="figure">D</ref>, <ref type="figure">F</ref>, <ref type="figure">H</ref> ) . MT-CO2 and MT-CO3 encode subunits of cytoc hr ome c oxidase, which is involved in the reduction of oxygen to water. Decreases in MT-CO2 and MT-CO3 expression cause significant cytoc hr ome c oxidase and mitochondrial complex IV deficiencies, which may lead to tissue maladaptations <ref type="bibr">[ 22 , 23 ]</ref>. Most mitochondrial genes return to basal levels of expression in our L-92 vs R + 82 comparison, suggesting relief from spaceflight-induced mitochondrial o xidati ve stress . DCs , monocytes , and T cells showed incr eased MT-ND4L expr ession ov er two months after r eturn fr om flight. The MT-ND4L gene encodes for NADH-ubiquinone oxidoreductase chain 4L, a component of the respiratory chain Complex I, a pr otein r equir ed for electr on tr ansfer and dehydr ogenation fr om NADH to ubiquinone. Longitudinal changes in its gene expression may suggest that mitochondrial ATP production is altered long after return to earth. Ho w ever, whether the gene expression is representativ e of decr eased activity of the electr on tr ansport c hain or if it is a physiological response seeking to r estor e mitoc hondrial function due to the hypofunctional aberrant effects of o xidati ve str ess, r emains to be elucidated.</p><p>In the spaceflight liter atur e, human induced pluripotent stem cell-deri ved cardiom yocytes had increased expression of genes related to the mitochondrial electron transport chain, mitochondrial transit peptide, mitochondrial translocation, and mitoribosomes <ref type="bibr" target="#b23">[ 24 ]</ref>. The NASA Twins Study also r e v ealed tr ansient enrichment of mitochondrial signaling that returned to baseline in the r ecov ery period <ref type="bibr" target="#b24">[ 25 ]</ref>. Our findings, in contr ast, r e v eal a mor e complex picture of mitochondrial gene expression changes where some ar e consistentl y upr egulated acr oss cell types and others ar e tr ansientl y downr egulated in R + 1 but return to basal le v els in R + 82.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Immune adaptations to short duration spaceflight</head><p>Immune system dysregulation in crewmembers following spaceflight has been consistentl y r eported, r e v ealing ada ptiv e imm une system changes and general shifts to w ar ds a Th2 T cell phenotype <ref type="bibr">[ 26 , 27 ]</ref>. Space environment exposure leads to suppressed activ ation and r eduction in T cells, along with fluctuations in cytokine gene expr ession, suc h as increased TNF-a, interleukin-8, interleukin-1r a, thr ombopoietin, VEGF, and v arious c hemokines <ref type="bibr">[ 2 , 27 , 28 ]</ref>. Our PBMC phenotype analysis offers insight into alterations within immune cell subpopulations, cell state, and genotype associated with short-duration orbital flight in an all-civilian cr e w. PLCG2 is known for its role in immune cell signaling by cleaving PIP2 into IP3 and diacylgl ycer ol ( DAG ) , k e y second messenger molecules that are involved in immune and growth factor receptors <ref type="bibr">[ 29 ]</ref>. Additionally, although the exact physiological pathway is not known, PLCG2 has been found to positiv el y affect mitoc hondrial r espir ation <ref type="bibr" target="#b29">[ 30 ]</ref>. Dendritic cells exhibit incr eased AHR expression in R + 1 vs L-92 ( Fig. <ref type="figure" target="#fig_3">4</ref> , Supplememtary Fig. <ref type="figure" target="#fig_3">S4 C</ref> ) , a transcription factor known to promote the de v elopment of pr oinflammatory Th17 and Th22 cells <ref type="bibr">[ 31 , 32 ]</ref>. T-helper ( CD4 + ) populations pr esent decr eased IL-32 expr ession ( Supplememtary Fig. <ref type="figure" target="#fig_3">S4 D</ref> ) in R + 82 time points r elativ e to pr e-flight L-92, suggesting the tr ansient c hanges to ada ptiv e imm une function can last up to two months, a finding concurrent with the body of literature of spaceflight r esearc h <ref type="bibr" target="#b32">[ 33 ]</ref>.</p><p>Immune dysfunction involving cytotoxic T cells is a proposed side effect of space tr av el <ref type="bibr" target="#b33">[ 34 ]</ref>, associated with an elevated risk of opportunistic infections during spaceflight, such as latent herpes virus reactivation <ref type="bibr" target="#b34">[ 35 ]</ref>. Short-term exposure to spaceflight conditions may affect innate immune system components, including functional alterations of k e y immune cell populations like CD14 + monocytes and dendritic cells. Micr ogr avity-induced c hanges can r esult in decr eased neutr ophil and macr opha ge pha gocytic activity, thus affecting the initial response to pathogens . Moreo ver, microgra vity ma y alter monocyte maturation and function, which play a critical role in antigen presentation and T cell activation. <ref type="bibr" target="#b35">Kaur et al. ( 2005 )</ref> describe that, although the percentage of CD14 + monocytes was not significantly reduced in astronauts following spaceflight, days after landing, the ability of these cells to engulf pathogens , degranulate , and mount an imm une r esponse was reduced compared to that of gr ound contr ols <ref type="bibr" target="#b35">[ 36 ]</ref>. Though little is known about the influence of spaceflight on dendritic cell function, their role in inflammation is well c har acterized as the y play k e y roles in modulating cytokine pr oduction, mediating migr ation, and enhancing antigen ca ptur e and processing <ref type="bibr" target="#b36">[ 37 ]</ref>.</p><p>Finally, while the long-term effects of short-duration spaceflight on the immune system and the genome ar e minimall y understood, particularly in civilians and first-fliers, these data are critical as we expand human presence in orbit and deep space. Additional studies are needed across varying cell types, mission dur ation, and cr e w bac kgr ound, whic h can also help guide countermeasures.</p><p>Of note, the short-duration space shuttle studies revealed decr eased l ymphocyte r esponse, post-flight neutr ophil incr ease, and eosinophil decr ease, corr elating with in-flight str ess r ather than micr ogr avity <ref type="bibr">[ 28 , 38 , 39 ]</ref>. Latent her pesvirus r eactiv ation and cytomegalovirus shedding were also observed during space shuttle flights <ref type="bibr" target="#b17">[ 18 ]</ref>. Similar adaptations occurred during ISS missions, as cr e w members experienced mild infectious diseases, atypical allergies, or dermatitis without significant operational impact <ref type="bibr">[ 18 , 32 ]</ref>, which seemed to be a function of mission duration. A 12-year ISS immune data comparison indicated improvements in immunity, stress, and viral reactivation due to operational and biomedical countermeasures onboard ISS, such as resupply frequency, impr ov ements in personal communication, exercise equipment, and food quality and variety, suggesting the potential for improved quality of life on the health of astr onauts <ref type="bibr" target="#b39">[ 40 ]</ref>. Suc h oper ational and biomedical considerations from earlier missions, as well as the cellular and molecular data shown here, can help future crews and missions maintain cr e w health and safety, as well as guide efforts for lifetime health studies of astronauts.</p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Figure 1 .</head><label>1</label><figDesc>Figure 1. Telomere length dynamics, mitochondrial, and cell-free DNA cell lysis Identity as a function of spaceflight. ( A ) Telomere length dynamics assessed by MMqPCR in I4 cr e w members. Normalized analysis shows increased average telomere length during orbital flight compared to pre-flight baseline and in R + 1 compared to pre-flight through Tuk e y-corrected re peated measures ANOVA ( P &lt; 0.001 ) and ( P &lt; 0.02 ) , r espectiv el y. A r a pid decr ease in telomer e length was also seen after landing during post-flight r ecov ery months. ( B ) Autosomes do not show an y spaceflight-r elated c hange in RPKM ( reads per kilobase per million reads ) , as exemplified using chr21. The cf-mtDNA is significantly more enriched in all samples-significance le v els ( P -v alue ) of the Wilcoxon test are as follows: Pre-Flight &lt; 0.001, Post-Flight = 0.029, Recovery &lt; 0.001. ( C ) Observed cf-mtDNA levels show high inter-sample heterogeneity. ( D ) Tissue of origin deconvolution for circulating cfDNA fr a gments r e v eals an incr eased cfDNA signatur e of both ada ptiv e and innate immune cells post-landing and during reco very. T he enrichment of tissue signatures from the HPM [ 13 ] was calculated based on inferred gene expression and nucleosomal footprinting of the cfDNA fragments. Average correlation coefficients ( multiplied by -1 ) over technical replicates are depicted for each sample and time point. The heatmap was subsetted to relevant tissue signatures; extended data is available in S upplememtary Fig. S1 and TableS1, see online supplementary material. ( E ) Cross-examination of cfDNA origin deconvolution using each of I4 astronaut cell-subpopulation-specific expression mark ers, deri ved from peripheral blood ( PBMC ) dataset, supports the results in D. We note an incr eased pr esence of innate and ada ptiv e imm une cfDNA in R + 1 and R + 82 when compar ed to all other timepoints . T he extended data is a vailable in S upplememtary Tables S2 , see online supplementary material.</figDesc><graphic coords="5,59.52,53.71,482.04,539.40" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Figure 2 .</head><label>2</label><figDesc>Figure 2. Targeted deep sequencing of CHIP-related genes exhibit genomic stability and comparable mutational burden as a function of spaceflight. ( A ) Putati ve dri ver mutational burden of CHIP-related genes were found in two out of the four astronauts, longitudinal follow-ups demonstrate stability during the months leading and following spaceflight. ( B&amp;C ) Variant allele frequency of putative driver mutations ( chr2: g.25235778C &gt; G, chr2: g.25234347G &gt; C, chr2: g.25241591C &gt; A, chr2: g.25246732GTCGTGGC AC ACCGGGAAC AGCTTCCCCGC &gt; G, chr2: g.25247647G &gt; A, chr22: g.28734438C &gt; T, chr20: g.32434638AG &gt; A, chr4: g.105275662G &gt; T ) in subjects 003 and 004 remained comparable both during pre-flight timepoints and post-flight r ecov ery. ( D&amp;E ) Comparison of variant allele frequency of TET2.p.Cys1273Tyr mutation in TW ( spaceflight ) subject of the NASA Twins Study and variant allele frequency of DNMT3A.p.Trp698Ter and de-novo mutation DNMT3A.p.Asp856Gly in HR ( ground subject ) sho w ed a relative stable VAF during the initial stages of the study but an increased variant allele frequency through a 6 year follow-up period.</figDesc><graphic coords="7,112.01,53.79,377.28,595.32" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Figure 3 .</head><label>3</label><figDesc>Figure 3. Whole genome sequencing and variant calling reveals genomic stability post-flight. ( A )Comparison of variant consequences before and after spaceflight of genes with the greatest mutational burden demonstrates no gene is disproportionately mutated post-flight. We report unique counts of ( variant, effect annotation ) pairs per gene of interest. ( B ) De novo mutational comparison elucidates comparable mutational burdens at a genome-wide scale. Here we count variants as unique changes of reference to alternative alleles at a given position regardless of variant annotation. ( C ) Variant effect annotation for variants called in both timepoints shows most mutations are in non-coding regions. Variant annotations were ranked according to the se v erity of the v ariant effect estimated by Ensembl<ref type="bibr" target="#b14">[ 15 ]</ref>. We report unique counts of ( variant, effect annotation ) pairs across the whole genome. ( D ) Timepoint comparison of variant effect annotations across the whole genome shows no disproportional mutational load for variants called uniquely post-flight. Here we show the distribution for moderate to high-severity variants.</figDesc><graphic coords="8,53.90,53.68,482.04,391.44" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>Figure 4 .</head><label>4</label><figDesc>Figure 4. Differential gene expression and frequency of specific immune subsets reveals conserved, long and short-term adaptations across adaptive and innate immune cells. ( A ) F requenc y of CD8 T cells expressing genes. ( B-E ) CD8 T cell volcano plot comparison of differential gene expression in L-92 vs R + 1, L-92 vs R + 82 &amp; R + 1 vs R + 82. ( F ) Proportion of classical monocytes expressing genes. ( G-J ) Classical monocytes longitudinal differ ential expr ession in L-92 vs R + 1, L-92 vs R + 82, R + 1 vs R + 82 &amp; R + 1 vs all timepoints. ( K ) Pr oportion of dendritic cells expr essing genes. ( L-O ) Dendritic cells longitudinal differential expression in L-92 vs R + 1, L-92 vs R + 82, R + 1 vs R + 82 &amp; R + 1 vs all timepoints.</figDesc><graphic coords="9,87.01,53.79,427.68,595.32" type="bitmap" /></figure>
		</body>
		<back>

			<div type="funding">
<div><head>Ac kno wledgements</head><p>This study was supported by the <rs type="funder">Leukemia and Lymphoma Society</rs> ( Grants No. <rs type="grantNumber">LLS 9238-16</rs> and <rs type="grantNumber">MCL7001-18</rs> ) , the <rs type="funder">National Institutes of Health</rs> ( Grants No. <rs type="grantNumber">P01C A214274</rs>, <rs type="grantNumber">R01C A249054</rs> and <rs type="grantNumber">R01MH117406</rs> ) , and the <rs type="funder">WorldQuant Foundation, NASA</rs> ( Grants No. <rs type="grantNumber">80NSSC19K0432</rs>, <rs type="grantNumber">80NSSC22K0254</rs>, <rs type="grantNumber">NNH18ZTT001N-FG2</rs>, <rs type="grantNumber">NNX13AE45G</rs>, <rs type="grantNumber">NNX14AH50G</rs>, <rs type="grantNumber">NNX17AB26G</rs> ) .</p></div>
			</div>
			<listOrg type="funding">
				<org type="funding" xml:id="_w7VbgKA">
					<idno type="grant-number">LLS 9238-16</idno>
				</org>
				<org type="funding" xml:id="_8yWvPPu">
					<idno type="grant-number">MCL7001-18</idno>
				</org>
				<org type="funding" xml:id="_7cNmt3q">
					<idno type="grant-number">P01C A214274</idno>
				</org>
				<org type="funding" xml:id="_egX6AJn">
					<idno type="grant-number">R01C A249054</idno>
				</org>
				<org type="funding" xml:id="_3Trkfch">
					<idno type="grant-number">R01MH117406</idno>
				</org>
				<org type="funding" xml:id="_HQd6fSB">
					<idno type="grant-number">80NSSC19K0432</idno>
				</org>
				<org type="funding" xml:id="_8xnqgu7">
					<idno type="grant-number">80NSSC22K0254</idno>
				</org>
				<org type="funding" xml:id="_Pm32shw">
					<idno type="grant-number">NNH18ZTT001N-FG2</idno>
				</org>
				<org type="funding" xml:id="_Jg9H4zQ">
					<idno type="grant-number">NNX13AE45G</idno>
				</org>
				<org type="funding" xml:id="_6kp37VB">
					<idno type="grant-number">NNX14AH50G</idno>
				</org>
				<org type="funding" xml:id="_3SZCAbq">
					<idno type="grant-number">NNX17AB26G</idno>
				</org>
			</listOrg>
			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conflict of interest</head><p>Christopher E. Mason is a co-Founder of Cosmica Biosciences. Braden Tierney is compensated for consulting with Seed Health and Enzymetrics Biosciences on microbiome study design and holds an ownership stake in the former. K ell y Bolton r eceiv es r esearch funding from Servier and Bristol Myers Squibb and serves on the medical advisory board of GoodCell. K ell y Blease </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Supplementary materials</head><p>Supplementary materials are available at PCMEDI online.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Data and code availability</head><p>The data that support this study is available at the NASA GeneLab/NASA This Figshar e r e pository ad ditionall y contains figur es detailing the top most abundant taxa for each alignment algorithm before and after decontamination, and additional data, methods, and detailed cr e w bac kgr ound can be found in the collections pa per, pr otocol pa pers, and additional SOMA pac ka ge pa pers <ref type="bibr" target="#b40">[41]</ref><ref type="bibr" target="#b41">[42]</ref><ref type="bibr" target="#b42">[43]</ref><ref type="bibr" target="#b43">[44]</ref><ref type="bibr" target="#b44">[45]</ref><ref type="bibr" target="#b45">[46]</ref><ref type="bibr" target="#b46">[47]</ref><ref type="bibr" target="#b47">[48]</ref><ref type="bibr" target="#b48">[49]</ref><ref type="bibr" target="#b49">[50]</ref><ref type="bibr" target="#b50">[51]</ref>. Select data can be visualized online through the SOMA Data Explorer: <ref type="url" target="https://soma.weill.cornell.edu">https://soma.weill.cornell.edu</ref> . The GenBank viral database used was the most recent as of 2022-07-26. The GTDB database used was the 202 release . T he MetaPhlan4 database w as mpa_vJ an21_CHOCOPhlAnSGB_202103. The Kraken2 database contained all NCBI listed taxa ( bacteria, fungal, and viral genomes ) in RefSeq, as of 2022-09-01. The Phanta database was the most recent as of 2022-08-01. The Bakta databases were the most recent as of 2022-08-18. Code used to generate Figures and analyses from this project is available at the GitHub repository for code sharing and annotation: <ref type="url" target="https://github.com/eliah-o/inspiration4-omics">https://github.com/eliah-o/inspiration4-omics</ref> .</p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Space medicine in the era of civilian spaceflight</title>
		<author>
			<persName><forename type="first">J</forename><surname>Stepanek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">S</forename><surname>Blue</surname></persName>
		</author>
		<idno type="DOI">10.1056/NEJMra1609012</idno>
		<ptr target="https://doi.org/10.1056/NEJMra1609012" />
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">380</biblScope>
			<biblScope unit="page" from="1053" to="1060" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Plasma cytokine concentrations indicate that in vivo hormonal regulation of immunity is altered during long-duration spaceflight</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">E</forename><surname>Crucian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">R</forename><surname>Zwart</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Mehta</surname></persName>
		</author>
		<idno type="DOI">10.1089/jir.2013.0129</idno>
		<ptr target="https://doi.org/10.1089/jir.2013.0129" />
	</analytic>
	<monogr>
		<title level="j">J Interferon Cytokine Res</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="page" from="778" to="786" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">The NASA twins study: A m ultidimensional anal ysis of a year-long human spaceflight</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">E</forename><surname>Garrett-Bakelman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Darshi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Green</surname></persName>
		</author>
		<idno type="DOI">10.1126/science.aau8650</idno>
		<ptr target="https://doi.org/10.1126/science.aau8650" />
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">364</biblScope>
			<biblScope unit="page">8650</biblScope>
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Retr ospectiv e anal ysis of somatic mutations and clonal hematopoiesis in astronauts</title>
		<author>
			<persName><forename type="first">A</forename><surname>Br Ojak Owska</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Kour</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Thel</surname></persName>
		</author>
		<idno type="DOI">10.1038/s42003-022-03777-z</idno>
		<ptr target="https://doi.org/10.1038/s42003-022-03777-z" />
	</analytic>
	<monogr>
		<title level="j">Commun Biol</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page" from="1" to="6" />
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Exposure of the bone marrow microenvironment to simulated solar and galactic cosmic radiation induces biological bystander effects on human hematopoiesis</title>
		<author>
			<persName><forename type="first">G</forename><surname>Almeida-Porada</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Rodman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Kuhlman</surname></persName>
		</author>
		<idno type="DOI">10.1089/scd.2018.0005</idno>
		<ptr target="https://doi.org/10.1089/scd.2018.0005" />
	</analytic>
	<monogr>
		<title level="j">Stem Cells Dev</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="page" from="1237" to="1256" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Clonal hematopoiesis before, during, and after human spaceflight</title>
		<author>
			<persName><forename type="first">N</forename><surname>Mencia-Trinchant</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Mackay</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Chin</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.celrep.2020.108458</idno>
		<ptr target="https://doi.org/10.1016/j.celrep.2020.108458" />
	</analytic>
	<monogr>
		<title level="j">Cell Rep</title>
		<imprint>
			<biblScope unit="volume">33</biblScope>
			<biblScope unit="page">108458</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Cell-fr ee DN A ( cfDN A ) and exosome profiling from a year-long human spaceflight reveals circulating biomarkers</title>
		<author>
			<persName><forename type="first">D</forename><surname>Bezdan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Grigor E V</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Meydan</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.isci.2020.101844</idno>
		<ptr target="https://doi.org/10.1016/j.isci.2020.101844" />
	</analytic>
	<monogr>
		<title level="j">iScience</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">The genetics of m yelod ysplastic syndr ome: fr om clonal haematopoiesis to secondary leukaemia</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">S</forename><surname>Sperling</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Gibson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">L</forename><surname>Ebert</surname></persName>
		</author>
		<idno type="DOI">10.1038/nrc.2016.112</idno>
		<ptr target="https://doi.org/10.1038/nrc.2016.1" />
	</analytic>
	<monogr>
		<title level="j">Nat Rev Cancer</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="5" to="19" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">The Sentieon Genomics Tools-A fast and accurate solution to variant calling from nextgener ation sequence data</title>
		<author>
			<persName><forename type="first">D</forename><surname>Freed</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Aldana</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Weber</surname></persName>
		</author>
		<idno type="DOI">10.1101/115717</idno>
		<ptr target="https://doi.org/10.1101/115717" />
	</analytic>
	<monogr>
		<title level="j">Pr eprint fr om bioRxiv</title>
		<imprint>
			<date type="published" when="2017-03-10">10 Mar 2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Clonal hematopoiesis in survivors of childhood cancer</title>
		<author>
			<persName><forename type="first">D</forename><surname>Novetsk Y F Riedman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Icc</forename><surname>Chan</surname></persName>
		</author>
		<author>
			<persName><surname>Mosko Witz Cs</surname></persName>
		</author>
		<idno type="DOI">10.1182/bloodadvances.2023009817</idno>
		<ptr target="https://doi.org/10.1182/bloodadvances.2023009817" />
	</analytic>
	<monogr>
		<title level="j">Blood Adv</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page" from="4102" to="4106" />
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Cancer ther a py sha pes the fitness landscape of clonal hematopoiesis</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">L</forename><surname>Bolton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">N</forename><surname>Ptashkin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Gao</surname></persName>
		</author>
		<idno type="DOI">10.1038/s41588-020-00710-0</idno>
		<ptr target="https://doi.org/10.1038/s41588-020-00710-0" />
	</analytic>
	<monogr>
		<title level="j">Nat Genet</title>
		<imprint>
			<biblScope unit="volume">52</biblScope>
			<biblScope unit="page" from="1219" to="1226" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">A draft map of the human proteome</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Pinto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Getnet</surname></persName>
		</author>
		<idno type="DOI">10.1038/nature13302</idno>
		<ptr target="https://doi.org/10.1038/nature13302" />
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">509</biblScope>
			<biblScope unit="page" from="575" to="581" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Telomere length dynamics and DNA damage responses associated with long-duration spaceflight</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Luxton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Mckenna</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Lewis</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.celrep.2020.108457</idno>
		<ptr target="https://doi.org/10.1016/j.celrep.2020.108457" />
	</analytic>
	<monogr>
		<title level="j">Cell Rep</title>
		<imprint>
			<biblScope unit="volume">33</biblScope>
			<biblScope unit="page">108457</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Inferring expressed genes by whole-genome sequencing of plasma DNA</title>
		<author>
			<persName><forename type="first">P</forename><surname>Ulz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">G</forename><surname>Thallinger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Auer</surname></persName>
		</author>
		<idno type="DOI">10.1038/ng.3648</idno>
		<ptr target="https://doi.org/10.1038/ng.3648" />
	</analytic>
	<monogr>
		<title level="j">Nat Genet</title>
		<imprint>
			<biblScope unit="volume">48</biblScope>
			<biblScope unit="page" from="1273" to="1278" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<monogr>
		<ptr target="https://grch37.ensembl.org/info/genome/variation/prediction/predicted_data.html" />
		<title level="m">Ensembl Variation-Calculated consequences</title>
		<imprint>
			<date type="published" when="2023-04-18">April 18, 2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Clonal hematopoiesis and its emerging effects on cellular ther a pies</title>
		<author>
			<persName><forename type="first">M</forename><surname>Von Bonin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">K</forename><surname>Jambor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Teipel</surname></persName>
		</author>
		<idno type="DOI">10.1038/s41375-021-01337-8</idno>
		<ptr target="https://doi.org/10.1038/s41375-021-01337-8" />
	</analytic>
	<monogr>
		<title level="j">Leukemia</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="page" from="2752" to="2758" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">High burden of clonal hematopoiesis in first responders exposed to the World Trade Center disaster</title>
		<author>
			<persName><forename type="first">S</forename><surname>Jasra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Giricz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Zeig-Owens</surname></persName>
		</author>
		<idno type="DOI">10.1038/s41591-022-01708-3</idno>
		<ptr target="https://doi.org/10.1038/s41591-022-01708-3" />
	</analytic>
	<monogr>
		<title level="j">Nat Med</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="page" from="468" to="471" />
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Immune responses and latent her pesvirus r eactiv ation in spaceflight</title>
		<author>
			<persName><surname>Sto W E Rp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">K</forename><surname>Mehta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Ferrando</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Aviat Space Environ Med</title>
		<imprint>
			<biblScope unit="volume">72</biblScope>
			<biblScope unit="page" from="884" to="891" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">The German ISS-experiment Cellular Responses to radiation in space ( CERASP ) : The effects of single and combined space flight conditions on mammalian cells</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">E</forename><surname>Hellweg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Thelen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Arenz</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.asr.2006.11.015</idno>
		<ptr target="https://doi.org/10.1016/j.asr.2006.11.015" />
	</analytic>
	<monogr>
		<title level="j">Adv Space Res</title>
		<imprint>
			<biblScope unit="volume">39</biblScope>
			<biblScope unit="page" from="1011" to="1018" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">How does spaceflight affect the acquired immune system?</title>
		<author>
			<persName><forename type="first">T</forename><surname>Akiyama</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Horie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Hinoi</surname></persName>
		</author>
		<idno type="DOI">10.1038/s41526-020-0104-1</idno>
		<ptr target="https://doi.org/10.1038/s41526-020-0104-1" />
	</analytic>
	<monogr>
		<title level="j">NPJ Microgravity</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page" from="1" to="7" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<monogr>
		<title level="m" type="main">MTRNR2L12 MT-RNR2 like 12 ( pseudogene ) [Homo sapiens ( human ) ]-Gene-NCBI</title>
		<ptr target="https://www.ncbi.nlm.nih.gov/gene/100463498" />
		<imprint>
			<date type="published" when="2023-04-18">April 18, 2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Novel point mutations in mitochondrial MT-CO2 gene may be risk factors for cor onary artery disease. A ppl Bioc hem</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Heidari</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">S</forename><surname>Mirfakhradini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Tayefi</surname></persName>
		</author>
		<idno type="DOI">10.1007/s12010-020-03275-0</idno>
		<ptr target="https://doi.org/10.1007/s12010-020-03275-0" />
	</analytic>
	<monogr>
		<title level="j">Biotec hnol</title>
		<imprint>
			<biblScope unit="volume">191</biblScope>
			<biblScope unit="page" from="1326" to="1339" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Decr eased expr ession of mitochondrial miR-5787 contributes to chemoresistance by repr ogr amming glucose metabolism and inhibiting MT-CO3 translation</title>
		<author>
			<persName><forename type="first">W</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Lu</surname></persName>
		</author>
		<idno type="DOI">10.7150/thno.37556</idno>
		<ptr target="https://doi.org/10.7150/thno.37556" />
	</analytic>
	<monogr>
		<title level="j">Theranostics</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page" from="5739" to="5754" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Effects of spaceflight on human induced pluripotent stem cell-derived car diomy oc yte structure and function</title>
		<author>
			<persName><forename type="first">A</forename><surname>Wnorowski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Sharma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Chen</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.stemcr.2019.10.006</idno>
		<ptr target="https://doi.org/10.1016/j.stemcr.2019.10.006" />
	</analytic>
	<monogr>
		<title level="j">Stem Cell Rep</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page" from="960" to="969" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Compr ehensiv e m ulti-omics anal ysis r e v eals mitoc hondrial str ess as a centr al biological hub for spaceflight impact</title>
		<author>
			<persName><surname>Da Silv Eir A</surname></persName>
		</author>
		<author>
			<persName><surname>Wa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Fazelinia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">B</forename><surname>Rosenthal</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.cell.2020.11.002</idno>
		<ptr target="tps://doi.org/10.1016/j.cell.2020.11.002" />
	</analytic>
	<monogr>
		<title level="j">Cell</title>
		<imprint>
			<biblScope unit="volume">183</biblScope>
			<biblScope unit="page" from="1185" to="1201" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Spaceflight/micr ogr avity inhibits the pr olifer ation of hematopoietic stem cells by decr easing kitras/cAMP-CREB pathw ay netw orks as evidenced b y RN A-seq assa ys</title>
		<author>
			<persName><forename type="first">P</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename></persName>
		</author>
		<idno type="DOI">10.1096/fj.201802413R</idno>
		<ptr target="https://doi.org/10.1096/fj.201802413R" />
	</analytic>
	<monogr>
		<title level="j">FASEB J Off Publ Fed Am Soc Exp Biol</title>
		<imprint>
			<biblScope unit="volume">33</biblScope>
			<biblScope unit="page" from="5903" to="5913" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Immune system dysregulation during spaceflight: potential countermeasures for deep space exploration missions</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">E</forename><surname>Crucian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Choukèr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Simpson</surname></persName>
		</author>
		<idno type="DOI">10.3389/fimmu.2018.01437</idno>
		<ptr target="https://doi.org/10.3389/fimmu.2018.01437" />
	</analytic>
	<monogr>
		<title level="j">F ront Immunol</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page">1437</biblScope>
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Alter ations in ada ptiv e imm unity persist during long-duration spaceflight</title>
		<author>
			<persName><forename type="first">B</forename><surname>Crucian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">P</forename><surname>Sto W E</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Mehta</surname></persName>
		</author>
		<idno type="DOI">10.1038/npjmgrav.2015.13</idno>
		<ptr target="https://doi.org/10.1038/npjmgrav.2015.13.29" />
	</analytic>
	<monogr>
		<title level="j">NPJ Microgravity</title>
		<imprint>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="page">15013</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<monogr>
		<title level="m" type="main">PLCG2-phospholipase C gamma 2 ( human )</title>
		<ptr target="https://pubchem.ncbi.nlm.nih.gov/gene/PLCG2/human" />
		<imprint>
			<date type="published" when="2023-04-17">April 17, 2023</date>
		</imprint>
		<respStmt>
			<orgName>PubChem</orgName>
		</respStmt>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">PLCG2 can exist in eccDNA and contribute to the metastasis of non-small cell lung cancer by r egulating mitoc hondrial r espir ation</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename></persName>
		</author>
		<idno type="DOI">10.1038/s41419-023-05755-7</idno>
		<ptr target="https://doi.org/10.1038/s41419-023-05755-7" />
	</analytic>
	<monogr>
		<title level="j">Cell Death Dis</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page" from="1" to="12" />
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Tuning T cells through the aryl hydrocarbon receptor</title>
		<author>
			<persName><forename type="first">Allan</forename><forename type="middle">S</forename></persName>
		</author>
		<idno type="DOI">10.1038/nri2319</idno>
		<ptr target="https://doi.org/10.1038/nri2319" />
	</analytic>
	<monogr>
		<title level="j">Nat Rev Immunol</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page">326</biblScope>
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Cytokine regulation in human CD4 T cells by the aryl hydrocarbon receptor and GPR68</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Mcaleer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Fan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Roar</surname></persName>
		</author>
		<idno type="DOI">10.4049/jimmunol.200.Supp.116.8</idno>
		<ptr target="https://doi.org/10.4049/jimmunol.200.Supp.116.8" />
	</analytic>
	<monogr>
		<title level="j">J Immunol</title>
		<imprint>
			<biblScope unit="volume">200</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page">116</biblScope>
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Immune system dysregulation during spaceflight: potential countermeasures for deep space exploration missions</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">E</forename><surname>Crucian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Choukèr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Simpson</surname></persName>
		</author>
		<idno type="DOI">10.3389/fimmu.2018.01437</idno>
		<ptr target="https://doi.org/10.3389/fimmu.2018.01437" />
	</analytic>
	<monogr>
		<title level="j">F ront Immunol</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page">1437</biblScope>
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">The effect of space and parabolic flight on macrophage hematopoiesis and function</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Armstr Ong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Cha</forename><surname>Gerr En Ra</surname></persName>
		</author>
		<author>
			<persName><surname>Sk</surname></persName>
		</author>
		<idno type="DOI">10.1006/excr.1995.1020</idno>
		<ptr target="https://doi.org/10.1006/excr.1995.1020" />
	</analytic>
	<monogr>
		<title level="j">Exp Cell Res</title>
		<imprint>
			<biblScope unit="volume">216</biblScope>
			<biblScope unit="page" from="160" to="168" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Impact of modeled micr ogr avity on migr ation, differ entiation, and cell cycle control of primitive human hematopoietic progenitor cells</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">A</forename><surname>Plett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Abonour</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Fr</forename></persName>
		</author>
		<idno type="DOI">10.1016/j.exphem.2004.03.014</idno>
		<ptr target="https://doi.org/10.1016/j.exphem.2004.03.014" />
	</analytic>
	<monogr>
		<title level="j">Exp Hematol</title>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="page" from="773" to="781" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Changes in monocyte functions of astronauts</title>
		<author>
			<persName><forename type="first">I</forename><surname>Kaur</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">R</forename><surname>Simons</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">A</forename><surname>Castro</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.bbi.2004.12.006</idno>
		<ptr target="https://doi.org/10.1016/j.bbi.2004.12.006" />
	</analytic>
	<monogr>
		<title level="j">Brain Behav Immun</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="page" from="547" to="554" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Dendritic cell migration in health and disease</title>
		<author>
			<persName><forename type="first">T</forename><surname>Worbs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">I</forename><surname>Hammerschmidt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Förster</surname></persName>
		</author>
		<idno type="DOI">10.1038/nri.2016.116</idno>
		<ptr target="https://doi.org/10.1038/nri.2016.116" />
	</analytic>
	<monogr>
		<title level="j">Nat Rev Immunol</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="30" to="48" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Neutrophil-tol ymphocyte r atio: A biomarker to monitor the immune status of astronauts</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Mhatr E Sd</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Cekanaviciute</surname></persName>
		</author>
		<idno type="DOI">10.3389/fimmu.2020.564950</idno>
		<ptr target="https://doi.org/10.3389/fimmu.2020.564950" />
	</analytic>
	<monogr>
		<title level="j">F ront Immunol</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page">564950</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Leukocyte subsets and neutrophil function after short-term spaceflight</title>
		<author>
			<persName><surname>Sto W E Rp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">F</forename><surname>Sams</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">K</forename><surname>Mehta</surname></persName>
		</author>
		<idno type="DOI">10.1002/jlb.65.2.179</idno>
		<ptr target="https://doi.org/10.1002/jlb.65.2.179" />
	</analytic>
	<monogr>
		<title level="j">J Leukoc Biol</title>
		<imprint>
			<biblScope unit="volume">65</biblScope>
			<biblScope unit="page" from="179" to="186" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">Space radiation and human exposures, a primer</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">A</forename><surname>Nelson</surname></persName>
		</author>
		<idno type="DOI">10.1667/RR14311.1</idno>
		<ptr target="https://doi.org/10.1667/RR14311.1" />
	</analytic>
	<monogr>
		<title level="j">Radiat Res</title>
		<imprint>
			<biblScope unit="volume">185</biblScope>
			<biblScope unit="page" from="349" to="358" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">The Space Omics and Medical Atlas ( SOMA ) : A compr ehensiv e data r esource and biobank for astronauts</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">G</forename><surname>Overbey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Ryon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Kim</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature In press</title>
		<imprint>
			<date type="published" when="2024">2024</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">The SpaceX Inspiration4 mission r e v eals inflight molecular and physiological metrics from an all-civilian crew</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Jones</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">G</forename><surname>Overbey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Lacombe</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature In press</title>
		<imprint>
			<date type="published" when="2024">2024</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">Single-cell multi-ome and imm une pr ofiles of the Inspir ation4 cr e w r e v eal conserv ed, celltype, and sex-specific responses to spaceflight</title>
		<author>
			<persName><forename type="first">J</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Tierney</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">G</forename><surname>Overbey</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Commun In press</title>
		<imprint>
			<date type="published" when="2024">2024</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">The microbiome architecture of short-term spaceflight and its potential link to host immune activation</title>
		<author>
			<persName><forename type="first">B</forename><surname>Tierney</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">G</forename><surname>Overbey</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Microbiol</title>
		<imprint>
			<date type="published" when="2024">2024</date>
		</imprint>
	</monogr>
	<note>In press</note>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">Spatial multi-omics of human skin r e v eals KRAS and inflammatory responses to spaceflight</title>
		<author>
			<persName><forename type="first">J</forename><surname>Ov Erbey Eg</surname></persName>
		</author>
		<author>
			<persName><surname>Nar Ayanan S</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Commun</title>
		<imprint>
			<date type="published" when="2024">2024</date>
		</imprint>
	</monogr>
	<note>In press</note>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main">Direct RNA sequencing of astronauts reveals spaceflight-associated epitranscriptome c hanges and str ess-r elated tr anscriptional r esponses</title>
		<author>
			<persName><forename type="first">T</forename><surname>Grigor E V K, Nelson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">G</forename><surname>Overbey</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Commun In press</title>
		<imprint>
			<date type="published" when="2024">2024</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main">Collection of biospecimens from the Inspiration4 Mission establishes the standards for the Space Omics and Medical Atlas ( SOMA )</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">G</forename><surname>Overbey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Ryon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Kim</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Commun</title>
		<imprint>
			<date type="published" when="2024">2024</date>
		</imprint>
	</monogr>
	<note>In press</note>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main">Secr etome pr ofiling ca ptur es acute changes in o xidati ve stress, brain homeostasis and coagulation from spaceflight</title>
		<author>
			<persName><forename type="first">N</forename><surname>Houerbi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><surname>Ov Erbey Eg</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Commun In press</title>
		<imprint>
			<date type="published" when="2024">2024</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main">Pr otectiv e alleles and pr ecision healthcare in crewed spaceflight</title>
		<author>
			<persName><forename type="first">L</forename><surname>Rutter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mackay</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Cope</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Commun</title>
		<imprint>
			<date type="published" when="2024">2024</date>
		</imprint>
	</monogr>
	<note>In press</note>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main">Astronaut omics and the impact of space on the human body at scale</title>
		<author>
			<persName><forename type="first">L</forename><surname>Rutter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Cope</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mackay</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Commun</title>
		<imprint>
			<date type="published" when="2024">2024</date>
		</imprint>
	</monogr>
	<note>In press</note>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main">Single Cell Analysis identifies conserv ed featur es of imm une dysfunction in sim ulated micr ogr avity and spaceflight</title>
		<author>
			<persName><forename type="first">W</forename><surname>Fu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Du</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Overbey</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Commun In press</title>
		<imprint>
			<date type="published" when="2024">2024</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
